Asthma Clinical Trials

Find Asthma Clinical Trials Near You

Randomised Controlled Trial Of Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to evaluate usual care versus biomarker-directed care (using blood eosinophil counts) for the management of asthma patients in primary care setting. The study hypothesizes that BEC is a valuable biomarker that can guide asthma treatment, and result in reduction in asthma exacerbations, better symptom control and improvement in quality of life compared to usual arm in mild to moderate asthma patients in the primary care setting. Researchers would compare using blood eosinophil count guided to usual care to see if biomarker-directed asthma treatment and management

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 65
Healthy Volunteers: f
View:

• Singaporeans or Singapore Permanent Residents

• Patients aged ≥21 to 65 years old

• Physician diagnosed asthma for duration of at least 4 weeks

• On or will be initiated on Global Initiative for Asthma (GINA) 2025 step 1-3) treatment

• No asthma exacerbations\* in the preceding 4 weeks before randomisation

• Able and willing to attend study appointments approximately every 4-monthly over a 1-year period

• Able to provide informed consent

• Stable cardiovascular status (i.e. controlled hypertension, no active symptoms of heart disease or arrhythmias) \*Exacerbations are defined as worsening of asthma symptoms requiring systemic corticosteroid for 3 or more days, emergency department visit, or hospitalization

Locations
Other Locations
Singapore
National Healthcare Group Polyclinics
RECRUITING
Singapore
Contact Information
Primary
Wern Ee Tang
wern.ee.tang@nhghealth.com.sg
(65) 6355 3000
Time Frame
Start Date: 2025-12-03
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 240
Treatments
Active_comparator: Biomarker-Directed Arm
Asthma management and treatment for participants in this group will be guided by blood eosinophil count (biomarker-directed).
Other: Control Arm (Usual Care)
Participants in the control arm will receive usual care, this does not involve the use of blood eosinophils
Related Therapeutic Areas
Sponsors
Collaborators: Singapore General Hospital, National Medical Research Council (NMRC), Singapore
Leads: National Healthcare Group Polyclinics

This content was sourced from clinicaltrials.gov